RecruitingNot applicableNCT07306962

Virtual Lesion Segmentation and Mandibular Ameloblastoma Radiographic Safety Margin

Studying Rare odontogenic tumor

Last synced from ClinicalTrials.gov May 3, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Alexandria University
Principal Investigator: yehia A El-Mahallawy, PhD
Faculty of Dentistry, Alexandria University, Alexandria, Alexandria
Intervention: Virtual lesion segmentation for mandibular ameloblastoma(device)
Enrollment: 10 enrolled
Eligibility: All sexes
Timeline: 2025 – 2027

Study locations (1)

Faculty of Dentistry, Alexandria University, Alexandria, Alexandria Governorate, Egypt

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07306962 on ClinicalTrials.gov

Other trials for Rare odontogenic tumor

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT06653517
Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

See all trials for Rare odontogenic tumor →

← Back to all trials